Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Current Deferred Revenue (2016 - 2020)

Trinity Biotech's Current Deferred Revenue history spans 5 years, with the latest figure at $4.4 million for Q4 2020.

  • On a quarterly basis, Current Deferred Revenue rose 1422.26% to $4.4 million in Q4 2020 year-over-year; TTM through Dec 2020 was $4.4 million, a 1422.26% increase, with the full-year FY2020 number at $4.4 million, up 1422.26% from a year prior.
  • Current Deferred Revenue hit $4.4 million in Q4 2020 for Trinity Biotech, up from $292000.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for TRIB hit a ceiling of $4.4 million in Q4 2020 and a floor of $224000.0 in Q4 2016.
  • Historically, Current Deferred Revenue has averaged $1.1 million across 5 years, with a median of $292000.0 in 2019.
  • Biggest five-year swings in Current Deferred Revenue: dropped 6.41% in 2019 and later soared 1422.26% in 2020.
  • Tracing TRIB's Current Deferred Revenue over 5 years: stood at $224000.0 in 2016, then increased by 24.11% to $278000.0 in 2017, then increased by 12.23% to $312000.0 in 2018, then dropped by 6.41% to $292000.0 in 2019, then soared by 1422.26% to $4.4 million in 2020.
  • Business Quant data shows Current Deferred Revenue for TRIB at $4.4 million in Q4 2020, $292000.0 in Q4 2019, and $312000.0 in Q4 2018.